Wilson Sonsini Goodrich & Rosati’s 2023 Mid-Year Technology and Life Sciences PIPE and RDO Report presents analysis related to 87 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based technology and life sciences companies between January 1 and June 30, 2023.
This report examines PIPEs and RDOs by operating companies and sets forth quantitative and qualitative results concerning proceeds and security types; registration rights; transfer restrictions; governance terms; protective covenants; conversion and redemption rights; anti-dilution protections; and other material transaction terms. The report is limited to transactions in which the company raised at least $10 million and had at least one closing in the first half of 2023.
Please see full publication below for more information.